Vedolizumab-Induced Reactive Arthritis: A Clinical Vignette

作者
Shalin Dipinkumar Shah,Steven Shamah,Arun C. Swaminath
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:111: S812-S813
标识
DOI:10.14309/00000434-201610001-01706
摘要

Introduction: Vedolizumab is a novel agent used to treat moderate to severe active Ulcerative Colitis (UC) and Crohn's Disease (CD). Reactive arthritis is not among the known adverse drug reactions associated with vedolizumab. Here we present a case of vedolizumab-induced reactive arthritis. Case: A 28 year-old female who had begun vedolizumab infusions for UC was admitted to the hospital with a fever (100.4°F/38°C), tachycardia (115 bpm), elevated inflammatory serum biomarkers (Table 1) and a swollen and painful left knee joint (Figure 1) presumed to be septic arthritis. She began empiric intravenous antibiotics but had no clinical response after 48 hours of therapy. Joint aspirate was negative for crystals and organisms (Table 1). Her urine and cervical STD panel was negative and IBD activity was at baseline. Additional history revealed that this was the patient's third episode of knee pain since starting her vedolizumab infusions. Her first infusion, 4 months prior, was followed by two days of mild left knee pain, which self-resolved. Her second infusion, two months after the first, was followed by 3 days of even worse but self-resolving left knee pain and swelling. She had not mentioned these episodes to her physician as they had resolved by the time of follow up.Figure 1Table 1: Lab investigationsGiven the non-response to antibiotics and the temporal relation between joint swelling and vedolizumab infusions, vedolizumab-induced reactive arthritis was suspected. She was switched from antibiotics to prednisone, with which her pain and swelling improved. Subsequent intra-articular triamcinolone injection brought full symptom resolution, further supporting the diagnosis. Discussion: Here, drug-induced reactive arthritis was diagnosed by excluding septic, crystal and IBD arthropathy and noting the temporal relation between drug infusions and symptom onset. Reactive arthritis has not been reported as an adverse reaction to vedolizumab. We recommend drug-induced reactive arthritis be considered in the differential diagnosis for any patient treated with vedolizumab who presents with mono-articular arthritis, and that patients treated with vedolizumab be questioned about joint swelling, even if self-limited. Further research is needed to elucidate the pathogenesis of this arthropathy, and refine management recommendations.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
杜胤江完成签到,获得积分10
1秒前
1秒前
su2589367856完成签到,获得积分10
1秒前
orixero的应助被feiyue126采纳,获得10
1秒前
REBECCA完成签到,获得积分10
1秒前
1秒前
J_Xu完成签到 ,获得积分10
1秒前
yjj发布了新的文献求助20
2秒前
lily发布了新的文献求助10
2秒前
ZZY完成签到,获得积分10
3秒前
爆米花的应助被科研通管家采纳,获得10
3秒前
陈哥完成签到,获得积分10
3秒前
Lucas的应助被科研通管家采纳,获得10
3秒前
顺顺利利的应助被科研通管家采纳,获得10
3秒前
Cyoka完成签到,获得积分10
3秒前
青橙的应助被科研通管家采纳,获得10
3秒前
罗lsz完成签到,获得积分10
3秒前
田様的应助被科研通管家采纳,获得10
3秒前
慢慢完成签到 ,获得积分10
3秒前
NexusExplorer的应助被科研通管家采纳,获得10
3秒前
少女闰土发布了新的文献求助10
4秒前
共享精神的应助被科研通管家采纳,获得10
4秒前
4秒前
可爱滴小花花完成签到,获得积分10
4秒前
秋风的应助被科研通管家采纳,获得10
4秒前
molihuakai的应助被科研通管家采纳,获得10
4秒前
飞飞的应助被科研通管家采纳,获得10
4秒前
方杰完成签到,获得积分10
4秒前
华仔的应助被科研通管家采纳,获得10
4秒前
4秒前
飞飞的应助被科研通管家采纳,获得10
4秒前
秋澄完成签到 ,获得积分10
5秒前
阿钦完成签到,获得积分10
5秒前
skmksd发布了新的文献求助10
5秒前
田様的应助被369ninja采纳,获得10
5秒前
5秒前
Chen完成签到,获得积分10
5秒前
HXX19完成签到,获得积分10
6秒前
Anothermoon完成签到,获得积分10
6秒前
sx完成签到,获得积分10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180146
求助须知:如何正确求助?哪些是违规求助? 9570319
关于积分的说明 21809739
捐赠科研通 7776294
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039